Date Range
Date Range
Date Range
Please click here to view. AbbVie and Eisai Obtain Additional Approval for New Indication of Fully Human Anti-TNF-α Monoclonal Antibody HUMIRA in the Treatment of Patients who have had an Inadequate Response to Conventional Therapy for Pustular Psoriasis.
YoKart - Multi Vendor Ecommerce System. YoKart - Multi Vendor System for Startups. Deals - Daily Deals System. FunAway - Travel Activity Marketplace Builder. Growcer - Online Grocery Store Builder. Stitch - Custom Tailoring Portal. YoYumm - Food Ordering Portal Builder. Care - Care Services Marketplace Solution. VivoGigs - Performance Gigs Marketplace Solution. QBuddy - Q and A Website System. Tree - Classified Ads Portal Builder. Meals - Cooked Meal Delivery System.
Please click here to view. AbbVie and Eisai Obtain Additional Approval for New Indication of Fully Human Anti-TNF-α Monoclonal Antibody HUMIRA in the Treatment of Patients who have had an Inadequate Response to Conventional Therapy for Pustular Psoriasis.
Zusammenarbeit mit Patientenorganisationen in Deutschland. Zusammenarbeit mit Patientenorganisationen in à sterreich. Leistungen an Fachkreise in Deutschland. Leistungen an Fachkreise in à sterreich. Auf dem globalen Pharmamarkt zà hlt Eisai zu den fà hrenden forschungs-.